NDC 62135-453 – Acarbose
Acarbose 25 mg/1 · Tablet · Oral
Product NDC62135-453
Product details
- Brand name
- Acarbose
- Generic name
- Acarbose
- Labeler
- Chartwell RX, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202271
- Marketed since
- April 16, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- alpha-Glucosidase Inhibitor
Active ingredients
- Acarbose 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62135-453-90 | 90 TABLET in 1 BOTTLE (62135-453-90) | Jan 31, 2023 |
Other Acarbose products
- 63629-5698 Acarbose 50 mg/1 · Tablet · Bryant Ranch Prepack
- 71335-9725 Acarbose 50 mg/1 · Tablet · Bryant Ranch Prepack
- 62135-454 Acarbose 50 mg/1 · Tablet · Chartwell RX, LLC
- 62135-455 Acarbose 100 mg/1 · Tablet · Chartwell RX, LLC
- 23155-147 Acarbose 25 mg/1 · Tablet · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-148 Acarbose 50 mg/1 · Tablet · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-149 Acarbose 100 mg/1 · Tablet · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 0054-0140 Acarbose 25 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc.
- 0054-0141 Acarbose 50 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc.
- 0054-0142 Acarbose 100 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc.
- 72789-131 Acarbose 25 mg/1 · Tablet · PD-Rx Pharmaceuticals, Inc.
- 72789-132 Acarbose 50 mg/1 · Tablet · PD-Rx Pharmaceuticals, Inc.